940.02(2)(a)
(a) By manufacture, distribution or delivery, in violation of s.
961.41, of a controlled substance included in schedule I or II under ch.
961, of a controlled substance analog of a controlled substance included in schedule I or II under ch.
961 or of ketamine or flunitrazepam, if another human being uses the controlled substance or controlled substance analog and dies as a result of that use. This paragraph applies:
940.02(2)(a)1.
1. Whether the human being dies as a result of using the controlled substance or controlled substance analog by itself or with any compound, mixture, diluent or other substance mixed or combined with the controlled substance or controlled substance analog.
940.02(2)(a)2.
2. Whether or not the controlled substance or controlled substance analog is mixed or combined with any compound, mixture, diluent or other substance after the violation of s.
961.41 occurs.
940.02(2)(a)3.
3. To any distribution or delivery described in this paragraph, regardless of whether the distribution or delivery is made directly to the human being who dies. If possession of the controlled substance included in schedule I or II under ch.
961, of the controlled substance analog of the controlled substance included in schedule I or II under ch.
961 or of the ketamine or flunitrazepam is transferred more than once prior to the death as described in this paragraph, each person who distributes or delivers the controlled substance or controlled substance analog in violation of s.
961.41 is guilty under this paragraph.
